Kynam Capital Management, LP Syndax Pharmaceuticals Inc Transaction History
Kynam Capital Management, LP
- $1.28 Billion
- Q2 2024
A detailed history of Kynam Capital Management, LP transactions in Syndax Pharmaceuticals Inc stock. As of the latest transaction made, Kynam Capital Management, LP holds 5,722,057 shares of SNDX stock, worth $109 Million. This represents 9.15% of its overall portfolio holdings.
Number of Shares
5,722,057
Previous 5,660,000
1.1%
Holding current value
$109 Million
Previous $135 Million
12.79%
% of portfolio
9.15%
Previous 14.14%
Shares
10 transactions
Others Institutions Holding SNDX
# of Institutions
201Shares Held
87MCall Options Held
268KPut Options Held
76.8K-
Black Rock Inc. New York, NY7.91MShares$150 Million0.0% of portfolio
-
Wellington Management Group LLP Boston, MA7.34MShares$139 Million0.03% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.8MShares$91 Million0.0% of portfolio
-
Avoro Capital Advisors LLC New York, NY3.89MShares$73.8 Million1.09% of portfolio
-
State Street Corp Boston, MA3.62MShares$68.8 Million0.0% of portfolio
About Syndax Pharmaceuticals Inc
- Ticker SNDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 56,565,200
- Market Cap $1.07B
- Description
- Syndax Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer. Its lead product candidates are SNDX-5613, which is in phase 1/2 clinical trial targeting the binding interaction of Menin with the mixed lineage leukemia 1 protein for the treatment of MLL-rearranged (MLLr) and nucleophosmin...